DaVita Inc. (DVA) is a publicly traded Healthcare sector company. As of September 22, 2026, DVA trades at $182.82 with a market cap of $11.73B and a P/E ratio of 14.80. DVA moved +0.26% today. Year to date, DVA is +60.50%; over the trailing twelve months it is +40.09%. Its 52-week range spans $101.00 to $247.49. Analyst consensus is buy with an average price target of $238.80. Rallies surfaces DVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for DVA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $182.82 |
| Market Cap | $11.73B |
| P/E Ratio | 14.80 |
| EPS | $12.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $247.49 |
| 52-Week Low | $101.00 |
| Volume | 182 |
| Avg Volume | 0 |
| Revenue (TTM) | $14.01B |
| Net Income | $1.19B |
| Gross Margin | 0.00% |
6 analysts cover DVA: 0 strong buy, 3 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $238.80.